|
Volumn 11, Issue 17, 2001, Pages 2279-2282
|
Design and synthesis of glycolic and mandelic acid derivatives as factor Xa inhibitors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
BLOOD CLOTTING FACTOR 10A;
BLOOD CLOTTING FACTOR 10A INHIBITOR;
GLYCOLIC ACID DERIVATIVE;
MANDELIC ACID DERIVATIVE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
CHEMICAL REACTION;
CONTROLLED STUDY;
DEEP VEIN THROMBOSIS;
DRUG ACTIVITY;
DRUG BLOOD LEVEL;
DRUG DESIGN;
DRUG EFFECT;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
NONHUMAN;
RABBIT;
RAT;
THROMBOGENESIS;
ACETANILIDES;
AMIDINES;
ANIMALS;
BIOLOGICAL AVAILABILITY;
BLOOD COAGULATION TESTS;
DRUG DESIGN;
DRUG EVALUATION, PRECLINICAL;
FACTOR XA;
INHIBITORY CONCENTRATION 50;
INJECTIONS, INTRAVENOUS;
MANDELIC ACIDS;
PHENYLACETATES;
PLASMIN;
RABBITS;
RATS;
RATS, SPRAGUE-DAWLEY;
SERINE PROTEINASE INHIBITORS;
STRUCTURE-ACTIVITY RELATIONSHIP;
VENOUS THROMBOSIS;
|
EID: 17944369775
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(01)00447-4 Document Type: Article |
Times cited : (13)
|
References (22)
|